- Country: Italy
- Summary: Transposition of the eighth tranche of drugs 2022: LIPOSOMAL DOXORUBICIN
- ITT Ref No: 91673853
- Deadline: 31 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 26460.11
- Notice Type: Tender
- Document Ref. No.:Login to see details
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINTransposition of the eighth tranche of drugs 2022: LIPOSOMAL DOXORUBICIN - Italy Tender
The INMI L. SPALLAZANI IRCCS, a Government sector organization in Italy, has announced a new tender for Transposition of the eighth tranche of drugs 2022: LIPOSOMAL DOXORUBICIN . This tender is published on ItalyTenders under ITT Ref No: 91673853 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-31.
The estimated tender value is EUR 26460.11, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
